In vitro study on the immunological effect of bromelain and trypsin on mononuclear cells from humans

European Journal of Medical Research

Volumn 10, Issue 8, 2005, Pages 325-331

  Barth, H ^a,c   Guseo, A ^b   Klein, Reinhild ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Fejér County Hospital   (Hungary)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bromelain; Cytokines; Macrophages monocytes; Proteolytic enzymes; T cells; Trypsin

Indexed keywords

BROMELAIN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; THYMIDINE; TRITIUM; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MONONUCLEAR CELL; POSTVACCINAL ENCEPHALITIS; RANK SUM TEST; T LYMPHOCYTE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD; BROMELAINS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TRYPSIN;

EID: 24144442688     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kokron O, Micksche M, Cerni C, Titscher R, Wybra H. Proteolytic enzymes in the treatment of malignant pleural effusions and solid metastases. Chemotherapy 1976; 8: 517-521
2. Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. J Ethnopharmacol 1988; 22: 191-203
3. Leipner J, Iten F, Saller R. Therapy with proteolytic enzymes in rheumatic disorders. Bio-Drugs 2001; 15: 779-789
4. Tilwe GH, Beria S, Turakhia NH, Daftary GV, Schiess W. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthritis of knee joint: an open randomized controlled clinical trial. J Assoc Physicians India 2001; 49: 617-621
5. Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 2001; 58: 1234-1245
6. Shahid SK, Turakhia NH, Kundra M, Shanberg P, Daftary GV, Schiess W. Efficacy and safety of phlogenzym, a protease formulation, in sepsis in children. J Assoc Physicians India 2002; 50: 527-551
7. Desser L, Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I. Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood. Cancer Chemother Pharmacol 2001; 47: S10-S15
8. Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8 and leu8/LAM 1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 1992; 149: 3809-3816
9. Lehmann PV. Immunomodulation by proteolytic enzymes. Nephrol Dial Transplant 1996; 11: 953-955
10. Desser L, Rehberger A, Krokon E, Paukovits W. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 1993; 50: 403-407
11. Desser L, Rehberger A, Paukovits W. Proteolytic enzymes and amylse induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biotherapy 1994; 9: 253-263
12. Eckert K, Grabowski E, Stange R, Schneider U, Eschmann K, Maurer HR. Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients. Oncol Rep 1999; 6: 1191-1199
13. Engwerda CR, Andrew D, Murphy M, Mynott TL. Bromelain activates murine macrophages and natural killer cells in vitro. Cell Immunol 2001; 25: 5-10
14. Engwerda CR, Andrew D, Ladhams A, Mynott TL. Bromelain modulates T cell and B cell immune responses in vitro and in vivo. Cell Immunol 2001; 25: 66-75
15. Mynott TL, Ladhams A, Scarmato P, Engwerda CR. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T-cells. J Tmmunol 1999; 163: 2568-2575
16. Targoni OS, Tary-Lehmann M, Lehmann PV. Prevention of murine EAE by oral hydrolytic enzyme treatment. J Autoimmun 1999; 12: 191-198
17. Roep BO, van den Engel NK, van Halteren AG, Duinkerken G, Martin S. Modulation of autoimmunity to beta-cell antigens by proteases. Diabetologia 2002; 45: 686-692
18. Mosmann TR, Coffmann RL. TH1 and ZH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7: 145-173
19. Romagnani S, Parronchi P, D'Elios NN, Romagnani P, Annunziato F, Piccinni MP, Manetti R, Sampgnara S, Mavilia C, De Carli M, Maggi E, Del Prete GF. An update on human Th1 and Th2 cells. Int Arch Allergy Immunol 1997; 113: 153-156
20. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18: 263-266
21. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davies FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtolle WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231
22. Barth H, Berg PA, Klein R. Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens. Clin Exp Immunol 2003; 134: 78-85
23. Brakebusch M, Wintergerst U, Petropoulou T, Notheis G, Husfeld L, Belohradsky BH, Adam D. Bromelain is an accelerator of phagocytosis, respiratory burst and killing of Candida albicans by human granulocytes and monocytes. Eur J Med Res 2001; 6: 193-200
24. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD. Proteinase-activated receptors: transducers of proteinase-mediated signalling in inflammation and immune response. Endocr Rev 2004; Oct 12 (Epub ahead of print)
25. Ristory G, Buzzi MG, Sabatini U, Giugni E, Bastianello S, Viselli F, Buttinelli C, Ruggieri G, Colonesse C, Pozzili C, Salvetti M. Use of bacille Calmette-Guérin (BCG) in multiple sclerosis. Neurology 1999; 53: 1588-1589
26. Stein GM, Berg PA. Mistletoe extract-induced effects of immunocompetent cells: in vitro studies.1 Anti-Cancer Drugs 1997; 8: S39-S42
27. Stein GM, Henn W, von Laue HB, Berg PA. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy. Eur J Med Res 1998; 3: 194-202
28. Groux H, Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today 1999; 20: 442-446
29. Weiner HL, Friedmann A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-837
30. Weiner HL. Oral tolerance : immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18: 335-342
31. Hale LP. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int Immunopharmacol 2004; 4: 255-264